Latest Share Placements News

ARC Funds Limited has secured $600,000 through a share placement priced at a 33% premium to its last traded price, aiming to strengthen its working capital and support growth initiatives.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.

Global Lithium Resources has completed a strategic placement raising A$7.32 million from Lopal, cementing a key partnership and advancing its Manna Lithium Project toward a final investment decision.

Accelerate Resources has raised A$2 million in a two-tranche placement to fund aggressive exploration at its Balagundi Gold and Woodie Woodie North Manganese projects, aiming for a busy news flow through 2026.

Beetaloo Energy has wrapped up its $5 million Share Purchase Plan with strong shareholder uptake, pending final approval at the upcoming AGM for new share issuance.

Thrive Tribe Technologies (ASX:1TT) has locked in A$4 million through a share placement to accelerate its AI-enabled workforce engagement software, targeting enterprise and defence sectors.

Anax Metals has closed the second tranche of its placement, raising $4.8 million through a share issue that included $1.1 million from directors and granted options to its lead manager.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Celsius Resources initiates emergency arbitration to halt Kiri’s offtake deals with Makilala Mining, while grappling with governance upheaval and stalled financing at its Philippine copper project.

TruScreen Group has secured NZ$1.82 million through an oversubscribed placement, underscoring investor confidence amid its global cervical screening expansion. The company also announced a renounceable rights issue and attaching options, both subject to shareholder approval.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.